GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,960,209 | -32.6% | 8,432,773 | -2.2% | 0.00% | -25.0% |
| Q2 2023 | $47,424,119 | -38.4% | 8,622,567 | -51.8% | 0.00% | 0.0% |
| Q1 2023 | $76,968,824 | +119.7% | 17,899,726 | +100.8% | 0.00% | +33.3% |
| Q4 2022 | $35,029,391 | -25.5% | 8,913,331 | +0.7% | 0.00% | -40.0% |
| Q3 2022 | $47,003,000 | -16.3% | 8,851,683 | +3.4% | 0.01% | -16.7% |
| Q2 2022 | $56,172,000 | -10.5% | 8,562,941 | +0.1% | 0.01% | +20.0% |
| Q1 2022 | $62,763,000 | +3.8% | 8,550,767 | +0.2% | 0.01% | +25.0% |
| Q4 2021 | $60,437,000 | -71.7% | 8,536,462 | +0.2% | 0.00% | -76.5% |
| Q3 2021 | $213,523,000 | -6.6% | 8,517,087 | +0.3% | 0.02% | -5.6% |
| Q2 2021 | $228,516,000 | -5.1% | 8,495,022 | +0.4% | 0.02% | -14.3% |
| Q1 2021 | $240,889,000 | +18.3% | 8,464,109 | +17.9% | 0.02% | +16.7% |
| Q4 2020 | $203,577,000 | -7.5% | 7,180,864 | -2.6% | 0.02% | -18.2% |
| Q3 2020 | $220,063,000 | +52.6% | 7,373,381 | -0.0% | 0.02% | +37.5% |
| Q2 2020 | $144,187,000 | – | 7,373,870 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |